Armenian banks’ investments in Government bonds grow 10.9% to AMD 135.3 billion

YEREVAN, March 14. /ARKA/. Armenian banks’ investments in government bonds reached AMD 135.3 billion in late January after growing 10.9% over the month.
The Central Bank of Armenia says in its monthly report that residents’ investments in government bonds totaled about AMD 208.5 billion in late January after contracting by 0.6%, compared with the previous month.
According to the report, banking investments accounted for 64.8% of government treasury bonds. The central bank’s share here was 23.3% in late January, and that of non-bank agents, dealers and investors was 11.8%.
Both residents and nonresidents’ investments in government treasury bonds totaled AMD 208.8 billion on Jan 31, after shrinking 0.6% over the month. ($1 – AMD 389.367). -0-

spot_img

POPULAR

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

US dollar, euro, and ruble up against  Armenian dram

YEREVAN, August 20. /ARKA/. The average market exchange rate for the US dollar to the Armenian dram on the Armenian foreign exchange market as of August 20, 2026, increased by 0.3 points to 365.26 drams compared to August 19.

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img